Abbott Laboratories Cartridge Gets FDA Clearance to be Used with Whole Blood
By Denny Jacob
Abbott Laboratories' i-STAT TBI cartridge received clearance from the Food and Drug Administration to be used with whole blood, offering an additional tool for people with suspected concussions.
The healthcare-products manufacturer said the cartridge's ability to use whole blood will provide lab-quality results in 15 minutes.
Abbott said the clearance will enable testing in new healthcare settings beyond hospital emergency departments including urgent care clinics with a certificate to perform moderate complexity tests.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 01, 2024 09:34 ET (13:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: Tech Stocks Lead Ahead of Nvidia Earnings
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Should You Buy and Hold an Artificial Intelligence Portfolio?
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis